Your browser doesn't support javascript.
loading
Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis.
Schiller Salton, Neta; Szwarcwort, Moran; Tzoran, Inna; Horowitz, Netanel A; Zuckerman, Tsila; Horesh, Nurit; Shachor-Meyouhas, Yael; Hussein, Khetam; Lavi, Noa.
Afiliação
  • Schiller Salton N; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Szwarcwort M; Virology Laboratory, Rambam Health Care Campus, Haifa, Israel.
  • Tzoran I; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Horowitz NA; Department of Hematology, Rambam Health Care Campus, Haifa, Israel.
  • Zuckerman T; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Horesh N; Department of Hematology, Rambam Health Care Campus, Haifa, Israel.
  • Shachor-Meyouhas Y; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Hussein K; Department of Hematology, Rambam Health Care Campus, Haifa, Israel.
  • Lavi N; Department of Hematology, Rambam Health Care Campus, Haifa, Israel.
Am J Hematol ; 96(12): E475-E478, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34622495
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunidade Humoral / Amiloidose de Cadeia Leve de Imunoglobulina / COVID-19 / Vacina BNT162 / Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunidade Humoral / Amiloidose de Cadeia Leve de Imunoglobulina / COVID-19 / Vacina BNT162 / Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel